HB5919, the Veterans HOPE Act, directs the Secretary of Veterans Affairs to complete a review of opioid overdose deaths among covered veterans for the five-year period preceding enactment. The review must be finished within 18 months and will catalog demographics, medications found at death, prescribing patterns, polypharmacy, and related factors.
It also requires the VA to publicly report the results and brief Congress. In addition, the Act directs actions to electronically track and dispose of unused opioids and to assess prescribing policies across VA facilities.
Beyond the review, the Act mandates that the VA identify and describe policies governing prescribing, implement electronic tracking of prescriptions, and establish disposal mechanisms for unused opioids. It also calls out a data-driven analysis intended to reduce veteran overdose rates and to illuminate gaps in care that may contribute to opioid-related deaths.
At a Glance
What It Does
The Act requires the VA to complete a formal review of veteran opioid overdoses within 18 months, covering a five-year window before enactment. It specifies a comprehensive set of data elements to collect and requires public reporting and congressional briefings.
Who It Affects
Covered veterans who died from opioid overdoses, VA medical centers and prescribers, VA researchers, and policymakers who rely on VA data for safety and quality improvements.
Why It Matters
Providing granular data on prescribing, polypharmacy, and disposal enables targeted safety interventions and policy changes within the VA system, with potential spillovers to veteran care outside VA.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Veterans HOPE Act tasks the Department of Veterans Affairs with a full, data-driven review of opioid overdose deaths among veterans who received VA care, looking back five years before enactment. The review must be completed within 18 months and will compile a range of information, including how many veterans died from opioid overdoses, their ages and demographics, the medications found in their systems, and the prescribing histories that may have contributed to overdose risk.
The law explicitly requires examining polypharmacy, the interval between last opioid prescription and death, and whether nonprescribed opioids played a role. It also directs attention to the prescribing policies in place at VA facilities and to how opioids are tracked, disposed of, and prevented from unintended diversion.
The Act requires the Secretary to publish the results in a public report within 45 days of completing the review and to brief Congress on the findings. It also calls for identification of VA facilities with high prescription and treatment rates, and for recommendations to improve safety and well-being for veterans.
Separately, it directs the VA to document and describe its policies governing prescribing of opioids and to pursue electronic tracking and disposal of unused or past-due opioids. Definitions for key terms, such as “covered veteran” and “black box warning,” are provided to guide the review and reporting.
The Five Things You Need to Know
The bill requires the VA to complete the overdose review within 18 months of enactment, covering the five years prior to enactment.
The review must list the medications found at time of death, highlighting any with black box warnings, off-label uses, or psychotropic properties.
The review analyzes prescribing histories and polypharmacy, including the number of concurrent medications and the time elapsed since the last opioid prescription.
The Act mandates electronic tracking and proper disposal of unused opioids, and identifies VA facilities with high prescription and treatment rates.
The Secretary must publish a public report and brief Congress within 45 days after completing the review, and define key terms for transparency.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title; purpose
This section designates the act’s official name as the Veterans Heroin Overdose Prevention Examination Act (Veterans HOPE Act) and establishes the purpose of directing a comprehensive VA review of veteran opioid overdose deaths to inform safety and policy improvements within the department.
Findings and Sense of Congress
This section sets out findings that veterans face rising opioid overdose deaths and that VA care users may be disproportionately affected by opioid use disorders. It also expresses a sense of Congress that overdose prevention efforts should extend beyond patients actively prescribed opioids, signaling a broader public health focus for VA policy and research.
Review of veteran opioid overdoses
This section requires the VA to complete the review within 18 months, focusing on the five-year window before enactment. It enumerates the data elements to be collected, including total deaths, demographic profiles, complete medication lists with annotations on black box warnings and psychotropic status, prescribing histories, instances of polypharmacy, and the timing between last opioid prescription and death. It also covers the identification of factors such as comorbid trauma and facility-level prescribing patterns.
Public availability and definitions
This section directs the publication of the review results to Congress and the public, and requires a briefing to the Veterans’ Affairs committees. It also defines key terms used in the review, including ‘black box warning’ and ‘covered veteran,’ to ensure consistent interpretation across reporting and analysis.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- VA prescribers and clinical staff gain clearer data to guide safer prescribing and monitoring practices.
- VA policymakers and administrators obtain evidence to shape guidelines and resource allocation.
- Researchers and public health officials can access VA data to study overdose risk factors and intervention points.
- Veterans and their families benefit from improved understanding of overdose risks and safer care pathways.
- Facilities with high prescription rates can be targeted for focused safety interventions and training.
Who Bears the Cost
- VA facilities incur additional data collection and reporting requirements that may require staffing or IT resources.
- VA’s information systems may need upgrades to support electronic tracking of prescriptions and disposal.
- Contractors or partners involved in disposal programs may face increased operational demands and costs.
- Clinicians and support staff may experience additional administrative tasks related to data documentation.
- Congress and GAO oversight may incur costs related to monitoring, auditing, and follow-up analyses.
Key Issues
The Core Tension
Balancing the imperative for granular, actionable data on veteran opioid overdoses with the costs, privacy considerations, and practical feasibility of implementing comprehensive tracking, disposal, and reporting within the VA system.
The bill creates a data-heavy review with potential privacy considerations, operational burdens, and reliance on VA data quality. Implementing electronic tracking and disposal of opioids across facilities will require coordination among multiple VA divisions and with outside partners, potentially driving up administrative costs and needing new IT capabilities.
There is a risk that granular data could be incomplete or misinterpreted if records are fragmented across care settings, which could affect the reliability of conclusions. Privacy protections and appropriate handling of sensitive health information must be maintained as part of any data-sharing and public reporting.
There is also a tension between the need for detailed, actionable insights and the practical constraints of VA infrastructure, staffing, and budget. The act’s effectiveness depends on consistent data collection, timely reporting, and the availability of resources to translate findings into concrete safety improvements, which is not guaranteed by the bill itself.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.